William (Bill) Abbott Email & Phone Number

Irvine, CA, US

Huntington Beach, California, US

• Led Finance and Administration for this early-stage developer of a Total Artificial Heart during pre-clinical through Early Feasibility Study/First-in-Human implantation. Hired to prepare/position company for future.
• Prepared company for first ever audit, engaged technical accounting specialists and received proposals from three of the Big 4 firms.
• Implemented IT security and training protocols, outsourced IT support.
• Managed $14M preferred stock offering and conversion of senior convertible debt.
• Negotiated 5-year lease for a state of the art medical device manufacturing and HQ facility based in Irvine, CA.
• Led conversion from a PEO (Professional Employer Organization) to a direct employer including rollout of new payroll system, benefit programs, 401(k) Plan and acquiring employer insurance coverages.

San Ramon, CA, US

• BioVentrix is a medical device company whose mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive.
• With CEO, led company reorganization and multiple reductions in force, repositioning the company to accelerate FDA trial completion and submission for product approval.
• Managed 2023 recapitalization and reverse stock split, combining four classes of equity in new common stock followed by the first $16M of a $48M new preferred stock offering.
• Managed three preferred stock offerings and debt offering raising $49M between 2019 and 2022.
• Completed acquisition of MateraCor, Inc., owner/licensor of a complimentary therapy.
• Launched a German subsidiary and led the process to transfer employees and operational activities.

• Early stage developer/manufacturer of bioprosthetic medical devices that establish improved standards of care for the treatment of cardiac and vascular diseases.
• Led S-1 Registration process including 7 amendments culminating in a successful Initial Public Offering (IPO) and listing on NASDAQ Capital Market in June 2018
• Key contributor and manager of 2 Preferred Stock Offerings and 2 Convertible Debt Offerings
• Led company through its first ever audits in preparation for initial public offering
• Built data room and instituted corporate governance protocols
• Assumed operational leadership role as President upon sudden death of CEO in June 2016 and successfully resolved several corporate governance issues which arose

• Led a 6 person accounting and finance team for this $45M integrated healthcare delivery company focused on improving medical outcomes with high-quality, cost-efficient care.
• Led S-1 registration statement efforts in conjunction with a $15M capital offering and stock uplisting to Nasdaq Capital Markets.
• Integrated financial functions of two recent acquisitions in the Hospice and Home Health markets

• Engagements included providing accounting and advisory services to support capital raising efforts, financial analysis to support patent litigation defense and preparation of GAAP financial statements and audit.

Kennesaw, Georgia, US

• CFO reporting to the Board of Directors (2006-2009) and CEO (2010-2011) for this $15M developer of surgical products used in the treatment of diffuse coronary artery disease. Led a 10 person team with $4M expense and.
• Completed sale of the company at a 43% premium to share price to CryoLife, Inc. (NYSE: CRY). Led due diligence efforts and supported negotiation efforts. Effectively managed transition and integration activities to.
• Resolved issues with the SEC related to certain prior revenue recognition practices
• Led efforts to bring the company current in its filings with the SEC (10-K and 10-Q’s)
• Achieved a very successful outcome in a mediation with the company’s former CEO
• Successfully recruited new members to the Board of Directors

Irvine, CA, US

• VP Finance & Treasurer reporting to the CFO for this $400M advanced technology capital equipment manufacturer. Led a 15 person team with a $7M expense and professional fees budget. Managed operational banking, $250M.
• Led, and participated in, due diligence efforts resulting in 8 acquisitions, with an aggregate value of $700M.
• Efficiently integrated the treasury functions of Spectra-Physics, Inc., a $300M acquisition.
• Implemented Sarbanes-Oxley 404 compliant processes and controls for the treasury, credit and collections, payroll and accounts payable functions.
• Reduced overall bank fees by successful conversion and consolidation of banking relationships, streamlining of banking processes and negotiating new debt facilities with reduced interest rates.
• Effectively communicated results of tax and portfolio management initiatives and activities to Board of Directors and Board Committees.

Irvine, CA, US

• VP and Corporate Controller reporting to the CFO. Managed a 20 person team with expenditures of $3.5M. Accountable for financial reporting, external audit coordination, operating and strategic plans, SEC reporting and.
• Key contributor to a secondary offering of 3.1M shares of common stock which raised $330M. Wrote financial sections of the S-3 registration statement and coordinated all financial aspects of the offering.
• Efficiently managed multiple federal and state tax audits and negotiated over $1M of assessment reductions.
• Identified $3M of tax savings and led projects resulting in excess of $10M of overall tax benefits.
• Reduced the accounting close cycle from 7 to 5 days and developed monthly reporting package to provide timely financial and operational information.
• Implemented new financial account structure to streamline reporting and enhance consistency of informational reporting across all entities.

• VP & Corporate Controller for this $800M manufacturer/distributor of industrial packaging materials. Subsidiary of Amcor Limited, a $7B global packaging company. Managed a 14 person team. Responsible for US and.
• Negotiated substantial assessment reductions from Federal income tax, employment tax and state sales and use tax audits.
• Managed implementation of new systems (JD Edwards general ledger, accounts payable and fixed assets), which produced greater efficiency in financial reporting and analysis.
• Led departmental reorganization upgrading certain positions and personnel to produce a more responsive and effective finance group.

Uxbridge, West London, GB

Purchase, New York, US

Mba

Bs, Accounting